The European Commission has proposed a European Innovation Act aimed at two recurring obstacles for technology businesses: selling research-intensive products to public buyers and using intellectual property to secure finance.
The proposal would create an EU-wide framework for research-and-development procurement and a common approach to valuing intellectual property. The policy is designed to help ideas move from laboratories into products and to make it easier for firms—especially deep-tech businesses whose assets may be patents rather than buildings—to grow across the single market.
What would the European Innovation Act change?
On procurement, the proposal seeks clearer and more consistent rules for public bodies buying R&D services before a finished product exists. The Commission argues that larger, coordinated demand can give emerging suppliers a realistic first market and help buyers share development risk.
On finance, the plan would give the EU Intellectual Property Office a role in developing a standard valuation framework, a secondary market for IP transactions and an advisory centre. The underlying problem is straightforward: a young company may own valuable patents but still struggle to borrow because lenders lack a trusted way to price those assets.
Why are the economic estimates so large?
An analysis by the Commission’s Joint Research Centre modelled three measures in the proposal. Its conservative scenario estimated almost €256 billion in additional cumulative EU GDP over ten years and 238,000 additional jobs at the point of peak impact. An optimistic scenario reached almost €452 billion and 507,000 jobs.
Those numbers are projections produced by an economic model, not money already generated and not a forecast with certainty. They depend on assumptions about implementation, finance unlocked, supplier learning and the response of businesses across regions.
How could patents support borrowing?
Traditional secured lending works best when an asset has an observable price and can be sold if a borrower defaults. Patents are harder: their value depends on legal scope, remaining life, the technology’s commercial prospects and the availability of buyers. A shared valuation method could reduce some uncertainty without eliminating it.
The JRC estimates that the IP measure could lead to between €2.7 billion and €10.2 billion in additional IP-backed finance each year. Whether lenders actually adopt the framework—and on what terms—will determine how much of that potential is realised.
What role does public procurement play?
R&D procurement allows a public authority to pay competing suppliers to develop solutions to a defined problem. It differs from a conventional purchase because the product may not yet exist. The JRC’s analysis uses evidence that supplier benefits can extend beyond the contract through new knowledge, production methods and technology.
The Commission says annual EU R&D procurement is about €17.3 billion. Better coordination could create larger launch markets, but mandatory preferences, eligibility rules and enforcement details will matter to both taxpayers and suppliers.
What happens before the rules take effect?
The Act is a proposed regulation, so the final text must move through the EU legislative process. Businesses should not treat every announced feature as settled law. Parliament and Council negotiations can alter scope, timing and obligations.
The practical questions are now legal and operational: how IP valuations will be standardised, who bears risk when a technology fails, how procurement remains competitive and how smaller firms gain access without creating new administrative burdens.
Reporting basis: Ferdiox reviewed the European Commission’s Innovation Act overview and proposal links and the Joint Research Centre’s macroeconomic analysis summary. Modelled outcomes are described as scenarios, not promises.
Featured image: Unsplash contributor; full attribution is stored with the image.